tokens: Biosimilars have found it difficult to get market share , which led biosimilar developer Pfizer to sue Johnson & Johnson over anticompetitive contracts with pharmacy benefit managers which bundle discounts ; these are sometimes called the " rebate wall " , and the rebates are generally unavailable to customers .